Ssp dnaB蛋白质内含子介导的重组人脑钠素的制备  

Use of Ssp dnaB Mini-intein as a Fusion Partner for Preparation of Recombinant Human Brain Natriuretic Peptide

作　　者：狄洌[1] 张宏伟[2] 徐朗莱[1] 

机构地区：[1]南京农业大学生命科学学院,南京210095 [2]江苏靖江市人民医院,靖江214500

出　　处：《生物工程学报》2006年第2期180-186,共7页Chinese Journal of Biotechnology

摘　　要：脑钠素(BNP)是临床治疗代偿失调性心衰竭的有效药物。将脑钠素与组氨酸标签(His-tag)以及具有自我剪切功能的Ssp dnaB微型蛋白质内含子进行融合表达。表达产物经Ni-Sepharose亲和层析及体外复性处理后,用CM_纤维素对复性产物进行了浓缩,并通过改变CM-纤维素柱内的pH及温度,诱导Ssp dnaB微型蛋白质内含子的剪切作用,使脑钠素从融合蛋白中释放并与载体蛋白(His-DnaB)分离,再经C4反相高效液相色谱法进一步纯化后,从每升培养液中获得了2.8mg纯度达97%的重组人脑钠素。体外活性测定结果表明,重组人脑钠素对兔胸主动脉条具有显著的血管舒张效应,其EC50为1.94×10-6mg/mL。Human brain natriuretic peptide （hBNP） was used clinically for the treatment of acute decompensated congestive heart failure. In this paper, hBNP was expressed as a fusion protein with a histidine tag and Ssp dnaB mini-intein which was capable of self-cleavage. After affinity chromatography with Ni-Sepharose and renaturation, the fusion protein was enriched with CM-cellulose. Ssp dnaB mini-intein mediated peptide-bond hydrolysis was triggered by shifting the pH and temperature in the CM-cellulose column, which let to the release of hBNP from the fusion protein and the separation of hBNP from His-DnaB. The hBNP sample was further purified by CA reverse phase HPLC, and 2.8mg of the peptide with homogeneity of 97% was obtained from one liter of culture medium. The biological activity was assayed in vitro, which indicated that hBNP had a potent vasodilatory effect on rabbit aortic strips with an EC50 of 1.94 ×10^-6mg/mL.

关 键 词：多肽制备 脑钠素 蛋白质内含子 蛋白质剪接 

分 类 号：TQ463.6[化学工程—制药化工]